Matches in SemOpenAlex for { <https://semopenalex.org/work/W2987505890> ?p ?o ?g. }
- W2987505890 endingPage "417" @default.
- W2987505890 startingPage "403" @default.
- W2987505890 abstract "Age-related macular degeneration (AMD) is a progressive retinal disorder characterized by imbalanced pro- and antiangiogenic signals. The aim of this study was to evaluate the effect of ex vivo cell-based gene therapy with stable expression of human pigment epithelium-derived factor (PEDF) release using the non-viral Sleeping Beauty (SB100X) transposon system delivered by miniplasmids free of antibiotic resistance markers (pFAR4). Retinal pigment epithelial (RPE) cells and iris pigment epithelial (IPE) cells were co-transfected with pFAR4-inverted terminal repeats (ITRs) CMV-PEDF-BGH and pFAR4-CMV-SB100X-SV40 plasmids. Laser-induced choroidal neovascularization (CNV) was performed in rats, and transfected primary cells (transfected RPE [tRPE] and transfected IPE [tIPE] cells) were injected into the subretinal space. The leakage and CNV areas, vascular endothelial growth factor (VEGF), PEDF protein expression, metalloproteinases 2 and 9 (MMP-2/9), and microglial/macrophage markers were measured. Injection with tRPE/IPE cells significantly reduced the leakage area at 7 and 14 days and the CNV area at 7 days. There was a significant increase in PEDF and the PEDF/VEGF ratio with tRPE cells and a reduction in the MMP-2 activity. Our data demonstrated that ex vivo non-viral gene therapy reduces CNV and could be an effective and safe therapeutic option for angiogenic retinal diseases. Age-related macular degeneration (AMD) is a progressive retinal disorder characterized by imbalanced pro- and antiangiogenic signals. The aim of this study was to evaluate the effect of ex vivo cell-based gene therapy with stable expression of human pigment epithelium-derived factor (PEDF) release using the non-viral Sleeping Beauty (SB100X) transposon system delivered by miniplasmids free of antibiotic resistance markers (pFAR4). Retinal pigment epithelial (RPE) cells and iris pigment epithelial (IPE) cells were co-transfected with pFAR4-inverted terminal repeats (ITRs) CMV-PEDF-BGH and pFAR4-CMV-SB100X-SV40 plasmids. Laser-induced choroidal neovascularization (CNV) was performed in rats, and transfected primary cells (transfected RPE [tRPE] and transfected IPE [tIPE] cells) were injected into the subretinal space. The leakage and CNV areas, vascular endothelial growth factor (VEGF), PEDF protein expression, metalloproteinases 2 and 9 (MMP-2/9), and microglial/macrophage markers were measured. Injection with tRPE/IPE cells significantly reduced the leakage area at 7 and 14 days and the CNV area at 7 days. There was a significant increase in PEDF and the PEDF/VEGF ratio with tRPE cells and a reduction in the MMP-2 activity. Our data demonstrated that ex vivo non-viral gene therapy reduces CNV and could be an effective and safe therapeutic option for angiogenic retinal diseases." @default.
- W2987505890 created "2019-11-22" @default.
- W2987505890 creator A5001784933 @default.
- W2987505890 creator A5014695135 @default.
- W2987505890 creator A5016030888 @default.
- W2987505890 creator A5016354085 @default.
- W2987505890 creator A5017123335 @default.
- W2987505890 creator A5024707203 @default.
- W2987505890 creator A5026295365 @default.
- W2987505890 creator A5036051094 @default.
- W2987505890 creator A5038330155 @default.
- W2987505890 creator A5043517944 @default.
- W2987505890 creator A5043659115 @default.
- W2987505890 creator A5045055554 @default.
- W2987505890 creator A5046433472 @default.
- W2987505890 creator A5050044807 @default.
- W2987505890 creator A5054187005 @default.
- W2987505890 creator A5054222559 @default.
- W2987505890 creator A5061223386 @default.
- W2987505890 creator A5066552100 @default.
- W2987505890 creator A5087028248 @default.
- W2987505890 date "2019-12-01" @default.
- W2987505890 modified "2023-10-18" @default.
- W2987505890 title "Preclinical Evaluation of a Cell-Based Gene Therapy Using the Sleeping Beauty Transposon System in Choroidal Neovascularization" @default.
- W2987505890 cites W1488341447 @default.
- W2987505890 cites W1500728559 @default.
- W2987505890 cites W1511562258 @default.
- W2987505890 cites W1651971811 @default.
- W2987505890 cites W180812339 @default.
- W2987505890 cites W1963486548 @default.
- W2987505890 cites W1964875773 @default.
- W2987505890 cites W1965376562 @default.
- W2987505890 cites W1968114550 @default.
- W2987505890 cites W1969157499 @default.
- W2987505890 cites W1971555156 @default.
- W2987505890 cites W1973394592 @default.
- W2987505890 cites W1975022071 @default.
- W2987505890 cites W1977955083 @default.
- W2987505890 cites W1979190481 @default.
- W2987505890 cites W1981313461 @default.
- W2987505890 cites W1985965517 @default.
- W2987505890 cites W1991955057 @default.
- W2987505890 cites W2001845497 @default.
- W2987505890 cites W2003688733 @default.
- W2987505890 cites W2008632796 @default.
- W2987505890 cites W2010104346 @default.
- W2987505890 cites W2010776166 @default.
- W2987505890 cites W2011752292 @default.
- W2987505890 cites W2031198310 @default.
- W2987505890 cites W203314557 @default.
- W2987505890 cites W2037005126 @default.
- W2987505890 cites W2041916290 @default.
- W2987505890 cites W2042345981 @default.
- W2987505890 cites W2043004414 @default.
- W2987505890 cites W2045289615 @default.
- W2987505890 cites W2061361780 @default.
- W2987505890 cites W2061731519 @default.
- W2987505890 cites W2064178034 @default.
- W2987505890 cites W2067626374 @default.
- W2987505890 cites W2068224058 @default.
- W2987505890 cites W2072387690 @default.
- W2987505890 cites W2074573698 @default.
- W2987505890 cites W2075701227 @default.
- W2987505890 cites W2086919152 @default.
- W2987505890 cites W2087624385 @default.
- W2987505890 cites W2087999614 @default.
- W2987505890 cites W2088147518 @default.
- W2987505890 cites W2089580488 @default.
- W2987505890 cites W2092558545 @default.
- W2987505890 cites W2092589001 @default.
- W2987505890 cites W2094547134 @default.
- W2987505890 cites W2094933313 @default.
- W2987505890 cites W2104630023 @default.
- W2987505890 cites W2122311980 @default.
- W2987505890 cites W2124789204 @default.
- W2987505890 cites W2124985265 @default.
- W2987505890 cites W2127430336 @default.
- W2987505890 cites W2127688669 @default.
- W2987505890 cites W2134158814 @default.
- W2987505890 cites W2134168653 @default.
- W2987505890 cites W2135325418 @default.
- W2987505890 cites W2138928327 @default.
- W2987505890 cites W2140362791 @default.
- W2987505890 cites W2146673937 @default.
- W2987505890 cites W2153581036 @default.
- W2987505890 cites W2158019017 @default.
- W2987505890 cites W2160226180 @default.
- W2987505890 cites W2166274173 @default.
- W2987505890 cites W2176213108 @default.
- W2987505890 cites W2183106684 @default.
- W2987505890 cites W2235976842 @default.
- W2987505890 cites W2237299736 @default.
- W2987505890 cites W2330576515 @default.
- W2987505890 cites W2333111179 @default.
- W2987505890 cites W2336307454 @default.
- W2987505890 cites W2342511528 @default.
- W2987505890 cites W2346208057 @default.
- W2987505890 cites W2411159809 @default.